These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 377697)

  • 1. Hepatocellular transplantation for treatment of D-galactosamine-induced acute liver failure in rats.
    Sommer BG; Sutherland DE; Matas AJ; Simmons RL; Najarian JS
    Transplant Proc; 1979 Mar; 11(1):578-84. PubMed ID: 377697
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hepatocyte transplantation - development of a clinical model].
    Henne-Bruns D; Gramminger K; Krüger U; Kremer B
    Z Gastroenterol Verh; 1987 Apr; 22():61-5. PubMed ID: 2442911
    [No Abstract]   [Full Text] [Related]  

  • 3. Influence of somatostatin on galactosamine-induced liver injury.
    Limberg B; Kommerell B
    Klin Wochenschr; 1986; 64 Suppl 7():64-5. PubMed ID: 2882052
    [No Abstract]   [Full Text] [Related]  

  • 4. An investigation of the hepatotoxicity of D-galactosamine in different species of animal.
    James GW; Pickering RW; Parker FL
    Arzneimittelforschung; 1975 Oct; 25(10):1593-4. PubMed ID: 1243045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal of experimental acute hepatic failure in the rat.
    Makowka L; Falk RE; Rotstein LE; Falk JA; Nossal N; Langer B; Blendis LM; Phillips MJ
    J Surg Res; 1980 Dec; 29(6):479-87. PubMed ID: 7001150
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies into the mechanism of reversal of experimental acute hepatic failure by hepatocyte transplantation. 1.
    Makowka L; Rotstein LE; Falk RE; Falk JA; Zuk R; Langer B; Blendis LM; Phillips MJ
    Can J Surg; 1981 Jan; 24(1):39-44. PubMed ID: 7006772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Liver-protecting and alanine aminotransferase lowering actions of hongning gantai].
    Chen Y; Li M; Xie T; Li W; Zhou J; He X
    Zhongguo Zhong Yao Za Zhi; 1995 May; 20(5):299-300, 312, 320, inside cover. PubMed ID: 7492364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Galactosamine hepatitis: injury to the plasma membrane of hepatic cells following administration of D-galactosamine].
    Reutter W; Bachmann W
    Verh Dtsch Ges Inn Med; 1971; 77():1177-8. PubMed ID: 5155984
    [No Abstract]   [Full Text] [Related]  

  • 9. Cellular transplantation in the treatment of experimental hepatic failure.
    Makowka L; Falk RE; Rotstein LE; Falk JA; Nossal N; Langer B; Blendis LM; Phillips MJ
    Science; 1980 Nov; 210(4472):901-3. PubMed ID: 7001630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of D-penicillamine on the galactosamine hepatitis model in the rat].
    Habersang S; Kozlik V; Leuschner F; von Schlichtegroll A
    Arzneimittelforschung; 1973 Jan; 23(1):56-7. PubMed ID: 4740696
    [No Abstract]   [Full Text] [Related]  

  • 11. [Preliminary observations on D-galactosamine-induced hepatic failure in rat models (author's transl)].
    Niu Z
    Zhonghua Yi Xue Za Zhi; 1981 Jun; 61(6):350-3. PubMed ID: 6796235
    [No Abstract]   [Full Text] [Related]  

  • 12. Influence of liver-RES on toxic liver damage due to galactosamine.
    Grün M; Liehr H; Grün W; Rasenack U; Brunswig D
    Acta Hepatogastroenterol (Stuttg); 1974 Feb; 21(1):5-15. PubMed ID: 4450963
    [No Abstract]   [Full Text] [Related]  

  • 13. Reversal of liver failure in rats by ultraviolet-irradiated hepatocyte transplantation.
    Kawai Y; Price JB; Hardy MA
    Transplant Proc; 1987 Feb; 19(1 Pt 2):989-91. PubMed ID: 3274437
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of viable isolated hepatocytes or hepatocyte fractions on survival rate following galactosamine-induced acute liver failure.
    ten Berg RG; Ernst P; van Maldegem-Dronkers C; Marquet R; Westbroek DL
    Eur Surg Res; 1985; 17(2):109-18. PubMed ID: 3884339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of intrasplenic injection of hepatocytes, hepatocyte fragments and hepatocyte culture supernatants on D-galactosamine-induced liver failure in rats.
    Baumgartner D; LaPlante-O'Neill PM; Sutherland DE; Najarian JS
    Eur Surg Res; 1983; 15(3):129-35. PubMed ID: 6345168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like growth factor-I prevents lethal acute liver failure induced by D-galactosamine and lipopolysaccharide in rats.
    Inoue T; Horiai H; Aoki C; Kawamura I; Ota M; Mizuhara H; Tomoi M; Mutoh S
    In Vivo; 2003; 17(3):293-9. PubMed ID: 12929583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salvage effect of E5564, Toll-like receptor 4 antagonist on d-galactosamine and lipopolysaccharide-induced acute liver failure in rats.
    Kitazawa T; Tsujimoto T; Kawaratani H; Fukui H
    J Gastroenterol Hepatol; 2010 May; 25(5):1009-12. PubMed ID: 20546456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microencapsulated hepatocytes for bioartificial liver support.
    Cai ZH; Shi ZQ; O'Shea GM; Sun AM
    Artif Organs; 1988 Oct; 12(5):388-93. PubMed ID: 3056346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of fasting on galactosamine induced hepatitis in experimental animals.
    Pickering RW
    Arzneimittelforschung; 1977; 27(10):1992-6. PubMed ID: 579109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Studies on the effect of liver cytosol on experimental acute hepatic failure in the rat].
    Ha TZ
    Zhonghua Yi Xue Za Zhi; 1989 May; 69(5):267-70, 18. PubMed ID: 2804738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.